Your browser doesn't support javascript.
loading
Evaluation of the efficacy of oral nano-silymarin formulation in hospitalized patients with COVID-19: A double-blind placebo-controlled clinical trial.
Aryan, Hossein; Farahani, Ramin Hamidi; Chamanara, Mohsen; Elyasi, Sepideh; Jaafari, Mahmoud Reza; Haddad, Mahboubeh; Sani, Ashraf Tavanaee; Ardalan, Mohamed Afshar; Mosaed, Reza.
Affiliation
  • Aryan H; Department of Anesthesiology and Intensive Care, Aja University of Medical Sciences, Tehran, Iran.
  • Farahani RH; Infectious Disease Research Center, AJA University of Medical Sciences, Tehran, Iran.
  • Chamanara M; Toxicology Research Center, Aja University of Medical Sciences, Tehran, Iran.
  • Elyasi S; Department of Pharmacology, School of Medicine, Aja University of Medical Sciences, Tehran, Iran.
  • Jaafari MR; Department of Clinical Pharmacy, School of Pharmacy Mashhad University of Medical Sciences, Mashhad, Iran.
  • Haddad M; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Sani AT; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Ardalan MA; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Mosaed R; Department of Infectious Diseases and Tropical medicine, Faculty of medicine, Mashhad University of medical sciences, Mashhad, Iran.
Phytother Res ; 36(10): 3924-3931, 2022 Oct.
Article in En | MEDLINE | ID: mdl-35859298
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Silymarin / COVID-19 Drug Treatment Type of study: Clinical_trials Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Silymarin / COVID-19 Drug Treatment Type of study: Clinical_trials Limits: Humans Language: En Year: 2022 Type: Article